Clinical Trial Update: Maintenance Phase Treatment With Divalproex for Post Traumatic Stress Disorder [Phase 4]

View source ↗

Summary

A Phase 4 maintenance-phase trial of divalproex for post-traumatic stress disorder was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• DEPAKOTE (DIVALPROEX SODIUM)
• DIVALPROEX SODIUM (divalproex sodium)

Snippet

Sponsor: Tuscaloosa Research & Education Advancement Corporation | Conditions: PTSD | Phase 4 | Status: TERMINATED